Recombinant DNA Advisory Committee - 09/9-10/93 
Jeffrey Ostrove, Microbiological Associates, Inc. 
Robert Overell, Targeted Genetics Corporation 
Seth Pauker, Parexel International 
Liz Pennisi, Science News 
Anne Petmska, FDC Reports 
Stephen Pijar, University of Maryland, Baltimore 
Doros Platika, Progenitor, Inc. 
Eckhard Podack, University of Miami School of Medicine 
Eric Poeschia, University of California, San Diego 
lisa Raines, Genzyme Corporation 
Urbin Ramstebt, Virus Research Institute 
Paul Recer, Associated Press 
Thomas Reynolds, Targeted Genetics Corporation 
Rex Rhein, Biotechnology Newswatch 
John Richards, University of Illinois at Chicago 
Phil Richards, Public 
Stanley Riddell, Fred Hutchinson Cancer Research Center 
Bruce Schackman, Furman Selz, Inc. 
Bill Schwieterman, Food and Drug Administration 
Terry Sharrer, Smithsonian Institution 
Tomiko Shimada, Ambience Awareness International, Inc. 
Marcus Stem, Copley Newspapers 
Frank Sturtz, Progenitor, Inc. 
Nevin Summers, Massachusetts Institute of Technology 
Colleen Sundstrom, Howard University 
Gary Temple, Life Technologies, Inc. 
Larry Thompson, Medical News Network 
George Thornton, The R.W. Johnson Pharmaceutical Research Institute 
Paul Tolstoshev, Genetic Therapy, Inc. 
Bruce Trapnell, Genetic Therapy, Inc. 
Joseph Van Houten, The R.W. Johnson Pharmaceutical Research Institute 
Christine Vanderpol, Rhone-Poulenc Rorer 
Ashley Wivel, Public 
Flossie Wong-Staal, University of California, San Diego 
Mang Yu, University of California, San Diego 
Recombinant DNA Research, Volume 18 
[185] 
